EmitBio Demonstrates New Treatment is Effective Against Multiple Types of Coronavirus

Strong antiviral effects achieved using safe, visible light on SARS-CoV-2 and MERS-CoV

Durham, N.C. (February 4, 2021) – EmitBio Inc., today announced new evidence from laboratory testing that demonstrates its proprietary light technology can inactivate multiple coronaviruses, beyond the coronavirus that causes COVID-19, to include the highly lethal Middle East Respiratory Syndrome coronavirus (MERS-CoV). These findings indicate a likelihood the company’s technology will also be effective against SARS-CoV-2 variants (mutations).